Back
Krystal Biotech 10K Form
Buy
53
KRYS
Krystal Biotech
Last Price:
$132.35
Seasonality Move:
12.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KRYS News And Ratings
See the #1 stock for the next 7 days that we like better than KRYS
KRYS Financial Statistics
Sales & Book Value
| Annual Sales: | $290.5M |
|---|---|
| Cash Flow: | $24.8M |
| Price / Cash Flow: | 30.48 |
| Annual Sales: | $34.07 |
| Price / Book: | 3.88 |
Profitability
| EPS (TTM): | 4.16000 |
|---|---|
| Net Income (TTM): | $124M |
| Gross Margin: | $270.5M |
| Return on Equity: | 13.91% |
| Return on Assets: | 12.69% |
Krystal Biotech Earnings Forecast
Key Krystal Biotech Financial Ratios
-
The Gross Profit Margin over the past 4 years for KRYS is 93.09%.
-
The Selling, General & Administrative Expenses for KRYS have been equal to 39.13% of Gross Profit Margin.
-
The Research & Development expenses have been 18.44% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of KRYS is 30.69% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Krystal Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KRYS |
| CUSIP: | 501147 |
| Website: | krystalbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.65 |
| Quick Ratio: | 9.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 44.03 |
|---|---|
| Forward P/E Ratio: | 12.06 |
KRYS Technical Analysis vs Fundamental Analysis
Buy
53
Krystal Biotech (KRYS)
is a Buy
Is Krystal Biotech a Buy or a Sell?
-
Krystal Biotech stock is rated a BuyThe current Krystal Biotech [KRYS] share price is $132.46. The Score for KRYS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.